Ilham is a highly accomplished cross-border attorney and regulatory strategist specializing in aligning complex healthcare, pharmaceutical, and medical device initiatives across international jurisdictions. She holds an LL.M. in U.S. and Comparative Law from the Fordham University School of Law, along with an advanced specialization in constitutional law (Especialidad en Amparo) and a five-year law degree from the Universidad Panamericana. Her elite educational foundation is further built upon advanced training from the Harvard Medical School Executive Program for Senior Life Sciences Leaders and the Yale School of Public Health, where she studied FDA Law.

At exFDA Consultants, Ilham bridges the intersection of legal strategy, policy, and global product commercialization. She specializes in designing and executing harmonized regulatory roadmaps that bridge the gap between US FDA standards and international authorities like Mexico's COFEPRIS. Her expertise allows life science companies to significantly shorten time-to-market, minimize redundant regulatory filings, and implement streamlined documentation strategies from the earliest stages of development.

Ilham’s distinguished track record includes launching a specialized Life Sciences legal practice alongside senior government figures, where she directly managed regulatory matters, facility certifications, and Good Manufacturing Practices (GMP) protocols while securing expedited product authorizations from COFEPRIS for top-tier global pharmaceutical companies. She is the Founding Partner of Kamar Associates, where she orchestrates multi-stakeholder healthcare workstreams and leads international pharmaceutical procurement tenders.

With a career spanning key global roles—including serving as an international anti-corruption compliance lawyer in Seoul, South Korea, working with a New York-based Bloomberg Associates team on municipal integrity, and acting as Chief of Staff and Finance Director within the Ministry of Foreign Affairs—Ilham brings unparalleled diplomatic weight and cross-border acumen. Fluent in both Spanish and English, she provides exFDA clients with the technical legal leverage and strategic vision required to navigate volatile global regulatory environments successfully.